NL-OMON43539已完成不适用
A randomized, double-blind, two-way crossover study to compare the pharmacokinetics, pharmacodynamics and safety of a single subcutaneous administration of LA-EP2006 and a single subcutaneous administration of Neulasta® (EU-authorized) in healthy subjects - LA-EP2006 Bioequivalence study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Hexal AG
- 入组人数
- 184
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male and female volunteers
- •- age 18 - 45 inclusive
- •- BMI between 19.0 and 28.0 kilograms/meter2
- •- weight ><= 60 kg
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 12 weeks from the start of the study.
研究者
相似试验
进行中（未招募）
不适用
Study to assess the effect of fluticasone furoate on growth rate in children aged 5-11Chronic disease of the lungs characterized by airway inflammation, bonchoconstriction and increased airway responsiveness.MedDRA version: 18.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2015-000841-22-DKGlaxoSmithKline Research and Development Ltd60
进行中（未招募）
1 期
Comparison of two daily dose regimens of tiotropium 5 µg once daily and tiotropium 2.5 µg twice daily for 4 weeks on top of maintenance therapy with an inhaled corticosteroid controller medicatioMedDRA version: 15.0Level: LLTClassification code 10003555Term: Asthma bronchialSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-001873-10-SIBoehringer Ingelheim RCV GmbH & Co KG92
进行中（未招募）
不适用
Comparison of two daily dose regimens of tiotropium 5 µg once daily and tiotropium 2.5 µg twice daily for 4 weeks on top of maintenance therapy with an inhaled corticosteroid controller medicatioEUCTR2012-001873-10-DEBoehringer Ingelheim Pharma GmbH & Co. KG92
进行中（未招募）
不适用
Comparison of two daily dose regimens of tiotropium 5 µg once daily and tiotropium 2.5 µg twice daily for 4 weeks on top of maintenance therapy with an inhaled corticosteroid controller medicatioEUCTR2012-001873-10-HUBoehringer Ingelheim RCV GmbH & Co KG92
进行中（未招募）
不适用
Comparison of two daily dose regimens of tiotropium 5 µg once daily and tiotropium 2.5 µg twice daily for 4 weeks on top of maintenance therapy with an inhaled corticosteroid controller medicatioEUCTR2012-001873-10-ATBoehringer Ingelheim RCV GmbH & Co KG92